外周动脉疾病血运重建患者慢性阿片类药物使用患病率
本研究基于单中心2013-2014年202例因间歇性跛行或严重肢体缺血行开放或腔内血运重建的PAD患者,使用北卡罗来纳州管制物质报告系统评估术前和术后慢性阿片类药物使用。约35%患者存在术前及术后慢性阿片使用,血运重建仅使不到15%的术前慢性使用者终止使用,而10%术前未慢性使用者术后开始慢性使用。
要点
- PAD血运重建患者术前和术后慢性阿片使用率均约35%。
- 血运重建后仅不到15%的术前慢性使用者终止慢性阿片使用。
- 约10%术前无慢性阿片使用的患者术后出现慢性使用。
核心结论
- PAD患者血运重建前后慢性阿片使用常见,患病率约35%。
- 血运重建仅使不到15%的术前慢性使用者终止慢性阿片使用。
- 约10%术前无慢性阿片使用的患者术后出现慢性使用。
研究设计与样本
- 单中心数据库分析2013至2014年因PAD行开放或腔内下肢血运重建的患者。
- 共纳入202例患者,其中开放手术108例(53.5%),腔内手术94例(46.5%)。
- 术前和术后慢性阿片使用定义为指数操作前后3个月内持续填写阿片类药物处方。
- 阿片处方填写情况通过北卡罗来纳州管制物质报告系统评估。
主要发现
- 术前慢性阿片使用与女性、慢性肌肉骨骼疼痛史、苯二氮䓬类药物使用及自报非法药物使用相关。
- 不到50%的患者报告使用非阿片类辅助镇痛药物。
- 术后中位ABI为0.88,术前慢性阿片使用与术后并发症、住院时间或死亡率无显著差异。
- 71例(35%)患者符合术后慢性阿片使用定义,其中14例无术前慢性阿片使用史,10例术前慢性使用者术后未再慢性使用。
临床怎么用
- PAD需血运重建患者是慢性阿片使用的高危人群,应加强识别。
- 优化非阿片类辅助镇痛药物的使用可能降低慢性阿片使用患病率及其不良反应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Opiate use, dependence, and the associated morbidity and mortality are major current public health problems in the United States. Little is known about patterns of opioid use in patients with peripheral arterial disease (PAD). The purpose of this study was to identify the prevalence of chronic preoperative and postoperative prescription opioid use in patients with PAD. A secondary aim was to determine the demographic, comorbid conditions, and operative characteristics associated with chronic opioid use. METHODS: Using a single-institution database of patients with PAD undergoing open or endovascular lower extremity intervention from 2013 to 2014, data regarding opiate use and associated conditions were abstracted for analysis. Patients were excluded if they did not live in North Carolina or surgery was not for PAD. Preoperative (PreCOU) and postoperative chronic opioid use (PostCOU) were defined as consistent opioid prescription filling in the 3 months before and after the index procedure, respectively. Opioid prescription filling was assessed using the North Carolina Controlled Substance Reporting System. Demographics, comorbid conditions, other adjunct pain medication data, and operative characteristics were abstracted from our institutional electronic medical record. Associations with PreCOU were evaluated using the t test, Wilcoxon test, or two-sample median test (continuous), or the χ2 or Fisher exact tests (categorical). RESULTS: A total of 202 patients undergoing open (108; 53.5%) or endovascular (94; 46.5%) revascularization for claudication or critical limb ischemia were identified for analysis. The mean age was 64.6 years, and 36% were female. Claudication was the indication for revascularization in 26.7% of patients, and critical limb ischemia was the indication in 73.3% of patients. The median preoperative ankle-brachial index (ABI) was 0.50. Sixty-eight patients (34%) met the definition for PreCOU. PreCOU was associated with female gender, history of chronic musculoskeletal pain, benzodiazepine use, and self-reported illicit drug use. Less than 50% of patients reported use of non-opiate adjunct pain medications. No association was observed between PreCOU and pre- or postoperative ABI, or number of prior lower extremity interventions. Following revascularization, the median ABI was 0.88. PreCOU was not associated with significant differences in postoperative complications, length of stay, or mortality. Overall, 71 patients (35%) met the definition for PostCOU, 14 of whom had no history of preoperative chronic opiate use. Ten patients with PreCOU did not demonstrate PostCOU. CONCLUSIONS: Chronic opiate use was common in patients with PAD with a prevalence of approximately 35%, both prior to and following revascularization. Revascularization was associated with a termination of chronic opiate use in less than 15% of patients with PreCOU. Additionally, 10% of patients who did not use opiates chronically before their revascularization did so afterwards. Patients with PAD requiring intervention represent a high-risk group with regards to chronic opiate use. Increased diligence in identifying opioid use among patients with PAD and optimizing the use of non-narcotic adjunct pain medications may result in a lower prevalence of chronic opiate use and its attendant adverse effects.
引用
- Velazquez-Ramirez G, Krebs J, Stafford JM, et al. Prevalence of chronic opioid use in patients with peripheral arterial disease undergoing revascularization. J Vasc Surg. 2021. PMID: 34478808. doi:10.1016/j.jvs.2021.07.236
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。